Maplight Therapeutics Inc. (MPLT) Live Share Price, Invest From India

Maplight Therapeutics Inc. Stock Performance

as on February 7, 2026 at 7:59 am IST

Day's Low
Day's High
$16.07
Day's Price Range
$17.19
$16.96
5.25%
Downside
1.36%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$16.96
100.00%
Downside
-100.00%
Upside

Maplight Therapeutics Inc. share price movements today

Previous Close: $15.70
Open: $16.22
Volume: 196.0K
Day's Low - High: $16.07 - $17.19

Maplight Therapeutics Inc. Historical Returns

1 Month Return: + 5.73 %
3 Month Return: + 8.78 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Maplight Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Maplight Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Maplight Therapeutics Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Maplight Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Maplight Therapeutics Inc.	NA	$-	NA	NA	0.00%

Maplight Therapeutics Inc. Stock’s Investor Sentiment and Interest

Search interest for Maplight Therapeutics Inc. Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 8, 2026 to February 7, 2026

Change:-15% versus previous 30 day period

Insights on Maplight Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, MPLT stock has moved down by -4.6%

About Maplight Therapeutics Inc.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients suffering from debilitating central nervous system disorders (CNS). Its lead product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist, ML-007, co-formulated with a peripherally acting anticholinergic (PAC), which it is initially developing for the treatment of schizophrenia and Alzheimer’s disease psychosis (ADP). ML-007C-MA is designed to activate both M1 and M4 muscarinic receptors in the CNS to drive efficacy, while synchronizing the pharmacokinetics of the agonist and antagonist components to mitigate peripheral cholinergic side effects. Its second product candidate, ML-004, is a 5-HT1B/1D agonist that the Company is developing for the treatment of social communication deficit and/or irritability in autism spectrum disorder. It is also advancing two preclinical programs, ML-021 and ML-009.

Organisation	Maplight Therapeutics Inc.
Headquarters	800 Chesapeake Drive, Redwood City, CA, United States, 94063
CEO	Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Maplight Therapeutics Inc.

Name	Title
Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D.	Founder, President, CEO & Director
Dr. Robert C. Malenka M.D., Ph.D.	Co-Founder, Director & Member of Scientific Advisory Board
Mr. Vishwas Setia	Chief Financial Officer
Dr. Karoly Nikolich Ph.D.	Founder
Mr. Jonathan Gillis CPA	Chief Administrative & Accounting Officer
Mr. Kristopher L. Hanson J.D.	General Counsel & Secretary
Dr. Erin Pennock Foff M.D., Ph.D.	Chief Medical Officer
Dr. Karl Deisseroth M.D., Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. James Woodruff Lillie Ph.D.	Chief Scientific Officer
Dr. Anatol Kreitzer Ph.D.	Chief Discovery Officer

FAQs

What is Maplight Therapeutics Inc. share price today?

Maplight Therapeutics Inc. share price today is $16.96 as on February 7, 2026 at 2:29 am IST at the close of the market. Maplight Therapeutics Inc. share today touched a day high of $17.19 and a low of $16.07.

What is the 52 week high and 52 week low for Maplight Therapeutics Inc. share?

Maplight Therapeutics Inc. share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. Maplight Therapeutics Inc. stock price today i.e. February 7, 2026 at 2:29 am IST is closed at $16.96,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Maplight Therapeutics Inc. Stock (MPLT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Maplight Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Maplight Therapeutics Inc. Shares that will get you 0.0884 shares as per Maplight Therapeutics Inc. share price of $16.96 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Maplight Therapeutics Inc. Stock (MPLT) from India?

Indian investors can start investing in Maplight Therapeutics Inc. (MPLT) shares with as little as ₹90.555 or $1 (as of February 7, 2026 at 10:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Maplight Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on February 7, 2026 at 10:42 pm IST). Based on Maplight Therapeutics Inc. share’s latest price of $16.96 as on February 7, 2026 at 2:29 am IST, you will get 0.5896 shares of Maplight Therapeutics Inc.. Learn more about fractional shares .

Maplight Therapeutics Inc. Share Price